About EUSA | People | Portfolio | Partners & Investors | News | Site Map | Contact

Partners

Zars

ZARS Pharma is a specialty pharmaceutical company focused on the development and commercialization of patented technologies that deliver drugs into and across the skin. 

EUSA Pharma has acquired the European commercialization rights from ZARS for Rapydan® , an advanced medicated plaster for the delivery of local an esthetics using patented CHADD® technology.

For more information see www.zars.com

 

Zars Pharma

 

Partners
Zars Pharma
Cambridge Laboratories
Health Protection Agency
AP-HP

Investors

 

 
Back to home page Disclaimer | Legal
Registered in England 4555273 Registered Office The Magdalen Centre, Oxford Science Park, Oxford OX4 4GA